Deepak Chemtex H1 Profit Rises to Rs 6.25 Crore, Revenue Up

CHEMICALS
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Deepak Chemtex H1 Profit Rises to Rs 6.25 Crore, Revenue Up

Deepak Chemtex Ltd reported a strong consolidated performance for the half-year ended September 30, 2026, with revenue climbing to Rs 39.86 crore and net profit rising to Rs 6.25 crore. The company maintains an unmodified auditor report.

Deepak Chemtex Reports Strong Half-Year Growth

Consolidated revenue stood at Rs 39.86 crore; net profit reached Rs 6.25 crore for H1 2026.

Reader Takeaway: Strong operational growth across consolidated and standalone segments with a clean, unmodified auditor report for investors.

What just happened

Deepak Chemtex Ltd announced its unaudited financial results for the half-year ended September 30, 2026. The company saw a robust increase in both its top-line revenue and bottom-line profit compared to the same period in 2025. Consolidated revenue from operations jumped from Rs 30.93 crore to Rs 39.86 crore, while consolidated net profit grew to Rs 6.25 crore from Rs 4.33 crore.

Why this matters

The growth reflects improved operational efficiency and market demand for the company’s products. The Basic and Diluted EPS improved to Rs 5.75, compared to Rs 3.99 in the previous year's corresponding half-year, indicating value creation for shareholders.

What changes now

The company’s standalone figures also showed steady improvement, with revenue rising to Rs 32.54 crore and net profit reaching Rs 3.75 crore. The statutory auditors, Mittal & Associates, have issued an unmodified review report, providing assurance on the compliance and accuracy of the financial reporting standards used.

Context metrics

The comparison period covers the half-year ending September 30, 2025, versus September 30, 2026. Standalone net profit showed a modest increase from Rs 3.43 crore to Rs 3.75 crore, confirming the broader consolidated gains are consistent across the group entities.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.